Initial screening (Tier 1) is done by IgG/IgM enzyme-linked immunosorbent assay (ELISA) using a whole cell lysate. Serology is the main laboratory diagnostic tool available for Lyme disease.Īs of April 1st 2023, PHO’s laboratory offers MTTT Borrelia burgdorferiELISA testing. burgdorferi antibodies uses a modified two-tiered testing approach (MTTT). As of April 1st 2023, PHO’s testing for B.Untreated, the disease may progress to the joints, the heart, and the nervous system. Initial symptoms may vary from asymptomatic to a combination of fever, headache, myalgia, stiff neck and fatigue, and may be accompanied by a characteristic circular or bull’s eye rash called erythema migrans (EM).
As a vector borne zoonotic disease, the bacterium is transmitted through the bite of a species of Ixodes ticks, thus most cases occur during the warmer months when the ticks are active. garinii is the most common species causing Lyme disease. In North America, the main causative agent is Borrelia burgdorferi sensu stricto, while in Europe, B. Lyme disease is caused by spirochetal bacteria of the genus Borrelia. For information regarding other testing options, refer to Lyme Disease PCR page. This page provides routine serology (antibody) testing information for Lyme disease (or Lyme Borreliosis) at Public Health Ontario’s (PHO) laboratory as well as testing referred out to the National Microbiology Laboratory (NML). Methods, Measures and Data Source Reviews Ontario Universal Typing of Tuberculosis (OUT-TB) Web Health Care-Associated Infection (HAI) Query Methicillin Resistant Staphylococcus aureus (MRSA) Locally Driven Collaborative Projects (LDCP) ProgramĬarbapenemase-Producing Enterobacteriaceae (CPE)Ĭlostridioides difficile Infections (CDI) Routine Practices and Additional Precautions Antimicrobial Stewardship in Long Term CareĪntimicrobial Stewardship in Primary CareĪntimicrobial Stewardship Program (ASP) & Antimicrobial Resistance (AMR) Comparison ToolĬonstruction, Renovation, Maintenance and Design
0 kommentar(er)
